AbbVie and Genmab Face Regulatory Test for Epcoritamab

This article discusses the potential outcomes for AbbVie Inc. as Genmab A/S encounters a new regulatory challenge concerning their drug Epcoritamab. It analyzes the implications for both pharmaceutical companies.